Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Mustang Bio's Pre-Tax Income for the
three
months ended in Mar. 2024 was $-5.19 Mil. Mustang Bio's Revenue for the
three
months ended in Mar. 2024 was $0.00 Mil. Therefore, Mustang Bio's pretax margin for the quarter that ended in Mar. 2024 was %.
The historical rank and industry rank for Mustang Bio's Pretax Margin % or its related term are showing as below:
MBIO's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.275 * Ranked among companies with meaningful Pretax Margin % only.
Mustang Bio Pretax Margin % Historical Data
The historical data trend for Mustang Bio's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mustang Bio's Pretax Margin %
For the Biotechnology subindustry, Mustang Bio's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mustang Bio's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Mustang Bio's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Mustang Bio's Pretax Margin % falls into.
Mustang Bio Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Mustang Bio's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mustang Bio (NAS:MBIO) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Mustang Bio Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Mustang Bio's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MBIO has been successfully added to your 